This technique, in conjunction with α-synuclein, can easily disseminate across the board of all amyloidogenic proteins such as tau, Aβ, and TDP-43, thus signifying a bright future in the field of drug development for the treatment of neurodegenerative diseases, via precision therapeutics. Here, MAPT is linked to neurodegenerative disease.